Dow Up 1.31% Nasdaq Up 2.40%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
4.70 Down 0.10(2.08%) 4:00PM EDT
|After Hours : 4.70 0.00 (0.00%) 4:30PM EDT
Prev Close:4.80
Open:4.83
Bid:4.53 x 100
Ask:4.95 x 800
1y Target Est:8.33
Beta:2.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.65 - 4.87
52wk Range:3.10 - 7.45
Volume:604,087
Avg Vol (3m):925,425
Market Cap:326.91M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 2.08%326.91M
DNDNDown 2.65%170.97M
NKTRDown 1.71%1.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-1.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback